Treatment of Ebola Virus Infection with Antibodies from Reconvalescent Donors

T. Kreil
DOI: https://doi.org/10.3201/eid2103.141838
IF: 16.126
2015-03-01
Emerging Infectious Diseases
Abstract:Clinical evidence suggests that antibodies from reconvalescent donors (persons who have recovered from infection) may be effective in the treatment of Ebola virus infection. Administration of this treatment to Ebola virus–infected patients while preventing the transmission of other pathogenic viruses may be best accomplished by use of virus-inactivated reconvalescent plasma.
What problem does this paper attempt to address?